DIVA Laboratories Ltd Capital Reinvestment Ratio
DIVA Laboratories Ltd capital reinvestment ratio. DIVA Laboratories Ltd (4153) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$5.57 Million) in capital expenditures (NT$241.00K). Check total reinvestment intensity of DIVA Laboratories Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of DIVA Laboratories Ltd (2017–2025)
Capital reinvestment ratio of DIVA Laboratories Ltd from 2017 to 2025. This chart tracks DIVA Laboratories Ltd's Capital Reinvestment Ratio across 7 annual periods. Also explore net asset growth rate of DIVA Laboratories Ltd to track the company's year-over-year net asset growth rate.
DIVA Laboratories Ltd Capital Reinvestment Ratio by Year (2017–2025)
DIVA Laboratories Ltd capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see 4153 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | NT$20.77 Million | NT$1.00 Million | ▲ +178.2% |
| 2024 | 0.02x | NT$123.14 Million | NT$2.13 Million | ▼ -43.1% |
| 2023 | 0.03x | NT$252.91 Million | NT$7.69 Million | ▼ -80.5% |
| 2022 | 0.16x | NT$73.19 Million | NT$11.42 Million | ▼ -35.8% |
| 2019 | 0.24x | NT$52.66 Million | NT$12.79 Million | ▼ -3.8% |
| 2018 | 0.25x | NT$86.02 Million | NT$21.71 Million | ▼ -21.4% |
| 2017 | 0.32x | NT$41.45 Million | NT$13.31 Million | — |